Glioblastoma cells negative for the anti-CD133 antibody AC133 express a truncated variant of the CD133 protein

International Journal of Molecular Medicine

Volumn 25, Issue 6, 2010, Pages 883-888

  Osmond, Taryn L ^a   Broadley, Kate W R ^a   McConnell, Melanie J ^a  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD133 ANTIBODY; MESSENGER RNA; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CELL MEMBRANE; CELL STRAIN CACO 2; CONTROLLED STUDY; CYTOPLASM; FLOW CYTOMETRY; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; MOLECULE; PRIORITY JOURNAL; RECOGNITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CELL LINE, TUMOR; EPITOPES; GENE EXPRESSION REGULATION; GLIOBLASTOMA; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; MICROSCOPY, CONFOCAL; MUTANT PROTEINS; PEPTIDES; RNA, MESSENGER; STRESS, PHYSIOLOGICAL;

EID: 77952788085     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000418     Document Type: Article

References (23)

1. Weigmann A, Corbeil D, Hellwig A and Huttner WB: Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci USA 94: 12425-12430, 1997.
2. Yin AH, Miraglia S, Zanjani ED, et al: AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90: 5002-5012, 1997.
3. Pallini R, Ricci-Vitiani L, Banna GL, et al: Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res 14: 8205-8212, 2008.
4. Dell'Albani P: Stem cell markers in gliomas. Neurochem Res 33: 2407-2415, 2008.
5. LaBarge MA and Bissell MJ: Is CD133 a marker of metastatic colon cancer stem cells? J Clin Invest 118: 2021-2024, 2008.
6. Jaksch M, Munera J, Bajpai R, Terskikh A and Oshima RG: Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines. Cancer Res 68: 7882-7886, 2008.
7. Chang CJ, Hsu CC, Yung MC, et al: Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression. Biochem Biophys Res Commun 380: 236-242, 2009.
8. Baba T, Convery PA, Matsumura N, et al: Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 28: 209-218, 2009.
9. Neuzil J, Stantic M, Zobalova R, et al: Tumour-initiating cells vs. cancer 'stem' cells and CD133: What's in the name? Biochem Biophys Res Commun 355: 855-859, 2007.
10. Miraglia S, Godfrey W, Yin AH, et al: A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning. Blood 90: 5013-5021, 1997.
11. Yi JM, Tsai HC, Glockner SC, et al: Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res 68: 8094-8103, 2008.
12. Shmelkov SV, Butler JM, Hooper AT, et al: CD133 expression is not restricted to stem cells, and both CD133(+) and CD133(-) metastatic colon cancer cells initiate tumors. J Clin Invest 118: 2111-2120, 2008.
13. Nicolis SK: Cancer stem cells and 'stemness' genes in neuro-oncology. Neurobiol Dis 25: 217-229, 2007.
14. Hide T, Takezaki T, Nakamura H, Kuratsu J and Kondo T: Brain tumor stem cells as research and treatment targets. Brain Tumor Pathol 25: 67-72, 2008.
15. Fomchenko EI and Holland EC: Stem cells and brain cancer. Exp Cell Res 306: 323-329, 2005.
16. Vezzoni L and Parmiani G: Limitations of the cancer stem cell theory. Cytotechnology 58: 3-9, 2008.
17. Joo KM, Kim SY, Jin X, et al: Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest 88: 808-815, 2008.
18. Jin F, Zhao L, Zhao HY, et al: Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on resistance-associated protein genes. Neuroscience 154: 541-550, 2008.
19. Platet N, Liu SY, El Atifi M, et al: Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. Cancer Lett 258: 286-290, 2007. (Pubitemid 350110377)
20. Kemper K, Sprick MR, de Bree M, et al: The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res 70: 719-729, 2010.
21. Bidlingmaier S, Zhu X and Liu B: The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med 86: 1025-1032, 2008.
22. Corbeil D, Joester A, Fargeas CA, et al: Expression of distinct splice variants of the stem cell marker prominin-1 (CD133) in glial cells. Glia 57: 860-874, 2009.
23. Liu G, Yuan X, Zeng Z, et al: Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5: 67, 2006. (Pubitemid 44942887)